Literature DB >> 27058678

Characterization of a mouse model of headache.

Dongyue Huang1, Lynn Ren1, Chang-Shen Qiu1, Ping Liu1, Jonathan Peterson1, Yuchio Yanagawa2, Yu-Qing Cao1.   

Abstract

Migraine and other primary headache disorders affect a large population and cause debilitating pain. Establishing animal models that display behavioral correlates of long-lasting and ongoing headache, the most common and disabling symptom of migraine, is vital for the elucidation of disease mechanisms and identification of drug targets. We have developed a mouse model of headache, using dural application of capsaicin along with a mixture of inflammatory mediators (IScap) to simulate the induction of a headache episode. This elicited intermittent head-directed wiping and scratching as well as the phosphorylation of c-Jun N-terminal kinase in trigeminal ganglion neurons. Interestingly, dural application of IScap preferentially induced FOS protein expression in the excitatory but not inhibitory cervical/medullary dorsal horn neurons. The duration of IScap-induced behavior and the number of FOS-positive neurons correlated positively in individual mice; both were reduced to the control level by the pretreatment of antimigraine drug sumatriptan. Dural application of CGRP(8-37), the calcitonin gene-related peptide (CGRP) receptor antagonist, also effectively blocked IScap-induced behavior, which suggests that the release of endogenous CGRP in the dura is necessary for IScap-induced nociception. These data suggest that dural IScap-induced nocifensive behavior in mice may be mechanistically related to the ongoing headache in humans. In addition, dural application of IScap increased resting time in female mice. Taken together, we present the first detailed study using dural application of IScap in mice. This headache model can be applied to genetically modified mice to facilitate research on the mechanisms and therapeutic targets for migraine headache.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27058678      PMCID: PMC4960827          DOI: 10.1097/j.pain.0000000000000578

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  70 in total

Review 1.  Migraine as an inflammatory disorder.

Authors:  Christian Waeber; Michael A Moskowitz
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

2.  Nitroglycerin induces hyperalgesia in rats--a time-course study.

Authors:  Cristina Tassorelli; Rosaria Greco; Dechun Wang; Maurizio Sandrini; Giorgio Sandrini; Giuseppe Nappi
Journal:  Eur J Pharmacol       Date:  2003-03-19       Impact factor: 4.432

3.  A neurohistochemical blueprint for pain-induced loss of appetite.

Authors:  A Malick; M Jakubowski; J K Elmquist; C B Saper; R Burstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

4.  Sensitization of meningeal sensory neurons and the origin of headaches.

Authors:  A M Strassman; S A Raymond; R Burstein
Journal:  Nature       Date:  1996-12-12       Impact factor: 49.962

5.  Vascular extracellular signal-regulated kinase mediates migraine-related sensitization of meningeal nociceptors.

Authors:  XiChun Zhang; Vanessa Kainz; Jun Zhao; Andrew M Strassman; Dan Levy
Journal:  Ann Neurol       Date:  2013-06-17       Impact factor: 10.422

6.  Behavioral differentiation between itch and pain in mouse.

Authors:  Steven G Shimada; Robert H LaMotte
Journal:  Pain       Date:  2008-09-11       Impact factor: 6.961

7.  Mast cell degranulation activates a pain pathway underlying migraine headache.

Authors:  Dan Levy; Rami Burstein; Vanessa Kainz; Moshe Jakubowski; Andrew M Strassman
Journal:  Pain       Date:  2007-04-24       Impact factor: 6.961

8.  5-Hydroxytryptamine(1B/1D) and 5-hydroxytryptamine1F receptors inhibit capsaicin-induced c-fos immunoreactivity within mouse trigeminal nucleus caudalis.

Authors:  D D Mitsikostas; M Sanchez del Rio; C Waeber
Journal:  Cephalalgia       Date:  2002-06       Impact factor: 6.292

9.  Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine.

Authors:  Ana Recober; Adisa Kuburas; Zhongming Zhang; John A Wemmie; Michael G Anderson; Andrew F Russo
Journal:  J Neurosci       Date:  2009-07-08       Impact factor: 6.167

10.  Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice.

Authors:  E A Bates; T Nikai; K C Brennan; Y-H Fu; A C Charles; A I Basbaum; L J Ptácek; A H Ahn
Journal:  Cephalalgia       Date:  2010-02       Impact factor: 6.292

View more
  14 in total

1.  Non-invasive dural stimulation in mice: A novel preclinical model of migraine.

Authors:  Carolina Christina Burgos-Vega; Lilyana D Quigley; Gabriela Trevisan Dos Santos; Flora Yan; Marina Asiedu; Blaine Jacobs; Marina Motina; Nida Safdar; Hayyan Yousuf; Amanda Avona; Theodore John Price; Greg Dussor
Journal:  Cephalalgia       Date:  2018-05-31       Impact factor: 6.292

2.  Cranial dural permeability of inflammatory nociceptive mediators: Potential implications for animal models of migraine.

Authors:  Jun Zhao; Dara Bree; Michael G Harrington; Andrew M Strassman; Dan Levy
Journal:  Cephalalgia       Date:  2016-08-19       Impact factor: 6.292

3.  C-Jun N-Terminal Kinase Post-Translational Regulation of Pain-Related Acid-Sensing Ion Channels 1b and 3.

Authors:  Clément Verkest; Sylvie Diochot; Eric Lingueglia; Anne Baron
Journal:  J Neurosci       Date:  2021-08-11       Impact factor: 6.167

Review 4.  A Comprehensive Review of Zavegepant as Abortive Treatment for Migraine.

Authors:  Nazir Noor; Alexis Angelette; Abby Lawson; Anjana Patel; Ivan Urits; Omar Viswanath; Cyrus Yazdi; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-06-28

5.  Low-dose interleukin-2 reverses behavioral sensitization in multiple mouse models of headache disorders.

Authors:  Jintao Zhang; Katherine Czerpaniak; Liang Huang; Xuemei Liu; Megan E Cloud; Jacqueline Unsinger; Richard S Hotchkiss; Daizong Li; Yu-Qing Cao
Journal:  Pain       Date:  2020-06       Impact factor: 7.926

6.  α7 Nicotinic acetylcholine receptor-mediated anti-inflammatory effect in a chronic migraine rat model via the attenuation of glial cell activation.

Authors:  Qing Liu; Chaoyang Liu; Li Jiang; Maolin Li; Ting Long; Wei He; Guangcheng Qin; Lixue Chen; Jiying Zhou
Journal:  J Pain Res       Date:  2018-06-15       Impact factor: 3.133

7.  Peripherally administered calcitonin gene-related peptide induces spontaneous pain in mice: implications for migraine.

Authors:  Brandon J Rea; Anne-Sophie Wattiez; Jayme S Waite; William C Castonguay; Chantel M Schmidt; Aaron M Fairbanks; Bennett R Robertson; Cameron J Brown; Bianca N Mason; Maria-Cristina Moldovan-Loomis; Leon F Garcia-Martinez; Pieter Poolman; Johannes Ledolter; Randy H Kardon; Levi P Sowers; Andrew F Russo
Journal:  Pain       Date:  2018-11       Impact factor: 7.926

8.  Creating a mouse model resistant to induced ischemic stroke and cardiovascular damage.

Authors:  Qing-Lan Ling; Anita J Mohite; Emma Murdoch; Hironari Akasaka; Qun-Ying Li; Shui-Ping So; Ke-He Ruan
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379

Review 9.  Behavioral and cognitive animal models in headache research.

Authors:  Doga Vuralli; Anne-Sophie Wattiez; Andrew F Russo; Hayrunnisa Bolay
Journal:  J Headache Pain       Date:  2019-01-31       Impact factor: 7.277

10.  A Pre-Existing Myogenic Temporomandibular Disorder Increases Trigeminal Calcitonin Gene-Related Peptide and Enhances Nitroglycerin-Induced Hypersensitivity in Mice.

Authors:  Hui Shu; Sufang Liu; Yuanyuan Tang; Brian L Schmidt; John C Dolan; Larry L Bellinger; Phillip R Kramer; Steven D Bender; Feng Tao
Journal:  Int J Mol Sci       Date:  2020-06-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.